mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.02 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.03 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |